Anúncio
Anúncio
ZNTL
Zentalis Pharmaceuticals, Inc. Common Stock
2.42
USDPatrocinado
+0.64
+36.24%
07 de jan., 15:58 UTC -5
Encerrado
Pós-Mercado
2.42
0.00
-0.21%
Relatórios de Lucros ZNTL
Rácio de surpresa positiva
ZNTL separação 12 de 23 últimas estimativas.
52%
Próximo Relatório
Data do Próximo Relatório
24 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.43
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+16.22%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-100.00%
/-30.65%
Zentalis Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, ZNTL reported earnings of -0.37 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 31.28% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analistas forecast an EPS of -0.43 USD, with revenue projected to reach -- USD, implying an aumentar of 16.22% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Zentalis Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Zentalis Pharmaceuticals, Inc. Common Stock reported EPS of -$0.37, beating estimates by 31.28%, and revenue of $0.00, 0% as expectations.
How did the market react to Zentalis Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 6.06%, changed from $1.32 before the earnings release to $1.40 the day after.
When is Zentalis Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 24 de mar. de 2026.
What are the forecasts for Zentalis Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 11
analistas, Zentalis Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.43 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio